Prophylaxis of VTE in the colorectal cancer patient
Colorectal cancer (CRC) is the third most common cancer worldwide and the most prevalent tumor in Western countries,...
Therapy
Treatment of VTE in the colorectal cancer patient
In clinical practice, cancer-associated thrombosis (CAT) is a frequent phenomenon among colorectal cancer (CRC)...
Drug-drug interaction prevalence in CAT patients
Drug-drug interactions (DDIs) between anticoagulants (AC) and anticancer therapies present a significant concern in the...
Managing anticoagulants in Cardio-Oncology
Cancer and cardiovascular disease (CVD) have shared risk factors and frequently occur together, particularly in elderly...
Polypharmacy in the Older Adult CAT Population
During the ICTHIC webinar titled “Challenges in the management of fragile CAT patients (older patient population...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
Twenty years of progress in CAT: an interview with Anna Falanga and Marina Marchetti
The scientific community has shown increased awareness of cancer-associated thrombosis (CAT) over the past two decades....
Immune checkpoint inhibitors and cancer-associated thrombosis: an overview
Immune checkpoint inhibitors (ICIs) are a type of immunotherapy that revolutionized cancer treatment and, in recent...
Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients
Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
The Impact of DDI on the Cancer Patient
Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...